Three great startups pass Venture Kick stage II
11.06.2018
Congratulations to DispenCell, DocsVisit AG and Resistell AG on winning CHF 20,000. They are now ready to go big and to try to win the Venture Kick final and CHF 100,000!
 DispenCell
|
 |
 DocsVisit
|
|
 Resistell
|
|
DispenCell (EPFL) BioTech (SEED Biosciences)
DispenCell focus on personalized medicine. To cope with long, expensive and complicated single cell isolation processes, the startup is developing a novel impedance-based technology. By using a novel pipetting systems, scientists can isolate single cells 3 times faster and 10 times cheaper than existing solutions. DispenCell wishes to introduce its robotic solution to the Biotech industry market and provide simple pipettes to the growing field of personalized medicine by selling affordable and intuitive pipettes to research labs.
DocsVisit (University of St. Gallen) Healthcare
DocsVisit is a trusted platform for medical practitioners connecting doctors and patients for home visits. Patients make appointments conveniently online or by phone and are matched with a physician in their area, that has the expertise and availability required, while the working style allows doctors to plan their hours of work flexibly and focus on frontline patient care.
Resistell (EPFL) – MedTech
Antibiotic resistance is among the top medical challenge of the 21st century. Resistell introduces a new device to help reduce the speed of diagnostics of antibiotic resistance. Currently, tests require a culture of 1-2-days in order to identify the pathogen. An additional 12 to 24h are needed to conduct antibiotic sensitivity screening, with the precise timescale depending on the type of bacteria and, with some bacteria requiring up to a month. Resistell therefore proposes an alternative based on the detection of movement caused by living bacterial cells. Cantilevers, used as sensors, oscillate when in contact with living bacteria. When the antibiotic is added, bacteria react and the cantilevers’ vibrations return to the level of an abiotic sample (sample without bacteria) within minutes. Simpler and faster than commercially available solutions, the automated device allows scientists to obtain results the same day.
DispenCell focus on personalized medicine. To cope with long, expensive and complicated single cell isolation processes, the startup is developing a novel impedance-based technology. By using a novel pipetting systems, scientists can isolate single cells 3 times faster and 10 times cheaper than existing solutions. DispenCell wishes to introduce its robotic solution to the Biotech industry market and provide simple pipettes to the growing field of personalized medicine by selling affordable and intuitive pipettes to research labs.
DocsVisit (University of St. Gallen) Healthcare
DocsVisit is a trusted platform for medical practitioners connecting doctors and patients for home visits. Patients make appointments conveniently online or by phone and are matched with a physician in their area, that has the expertise and availability required, while the working style allows doctors to plan their hours of work flexibly and focus on frontline patient care.
Resistell (EPFL) – MedTech
Antibiotic resistance is among the top medical challenge of the 21st century. Resistell introduces a new device to help reduce the speed of diagnostics of antibiotic resistance. Currently, tests require a culture of 1-2-days in order to identify the pathogen. An additional 12 to 24h are needed to conduct antibiotic sensitivity screening, with the precise timescale depending on the type of bacteria and, with some bacteria requiring up to a month. Resistell therefore proposes an alternative based on the detection of movement caused by living bacterial cells. Cantilevers, used as sensors, oscillate when in contact with living bacteria. When the antibiotic is added, bacteria react and the cantilevers’ vibrations return to the level of an abiotic sample (sample without bacteria) within minutes. Simpler and faster than commercially available solutions, the automated device allows scientists to obtain results the same day.